Mesa Laboratories reported Q1 2026 revenue of $63.7M (+2.6% YoY), missed analyst consensus of $65.2M by $1.5M. Diluted EPS came in at $3.30 (+48.0% YoY), beat the $2.09 consensus by $1.21.
Trailing eight quarters through Q1 2026 — latest period from 8-K press release; updates when 10-Q/10-K is filed
Common questions about Mesa Laboratories's Q1 2026 earnings report.
Mesa Laboratories (MLAB) reported Q1 2026 earnings on May 27, 2026 before market open.
Mesa Laboratories reported revenue of $63.7M and diluted EPS of $3.30 for Q1 2026.
Revenue missed the consensus estimate of $65.2M by $1.5M. EPS beat the consensus estimate of $2.09 by $1.21.
Compared to the same quarter a year prior, revenue grew 2.6% from $62.1M a year earlier and diluted EPS grew 48.0% from $2.23.
You can read the 8-K earnings release (0000724004-26-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.